A retrospective cohort study assessing efficacy and safety of dalbavancin as primary and sequential treatment of Gram-positive bacteremia with infective endocarditis
Latest Information Update: 25 Apr 2018
At a glance
- Drugs Dalbavancin (Primary)
- Indications Bacteraemia; Bacterial endocarditis; Gram-positive infections
- Focus Therapeutic Use
Most Recent Events
- 25 Apr 2018 New trial record
- 05 Apr 2018 Results published in the Clinical Infectious Diseases